Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signatures.
Journal: Cancer immunology, immunotherapy : CII
Published: December 02, 2025
Changes in Glucose level During Chemotherapy Treatment in Patients With Stage I-IV Breast Cancer.
Journal: Clinical breast cancer
Published: May 20, 2024
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.
Journal: Oncology and therapy
Published: January 08, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: September 02, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival.
Journal: Journal of cancer research and clinical oncology
Published: May 31, 2022
A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy.
Journal: Urologic oncology
Published: April 26, 2022
Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma.
Journal: Cancer medicine
Published: November 23, 2021
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival.
Journal: Cancer immunology, immunotherapy : CII
Published: June 02, 2021
Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience.
Journal: European journal of breast health
Published: April 27, 2021
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: May 29, 2020
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 30, 2020
Last Updated: 09/26/2026